NSG 448 Topic 3 evidence quality appraisal example

Evidence-Based Project Capstone Grand Canyon University Free custom sample in 24 to 48h

This NSG 448 Topic 3 sample paper grades, rather than counts, the evidence on checking criteria before C. difficile testing, using the Johns Hopkins tool from Dang and colleagues. It forms part of GCU NSG 448, Evidence-Based Project Capstone, catalog code NSG-448, taken within Grand Canyon University's BSN. Each source gets a level and a quality rating in a table: four studies, one guideline and the Kociolek and colleagues compendium. The studies agree in direction, but agreement among single-site designs is weighed carefully. Safety, a missed true infection, is examined with Madden and colleagues. Applicability to the composite floor is judged separately, and what the proposal may and may not say is set out.

CourseNSG 448 Evidence-Based Project Capstone
TopicTopic 3
Paper typeEvidence appraisal paper
LengthAbout 1,010 words, 3 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramBSN
UpdatedOctober 2026

Free sample paper for NSG 448 Topic 3

1

Graded, Not Counted: Appraising the Evidence on Checking Criteria Before C. difficile Testing With the Johns Hopkins Tool

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

NSG-448: Evidence-Based Project Capstone

Topic 3 Assignment

[Instructor Name]

October 18, 2027

What this page is doingThe title states the appraisal's rule: sources are weighed by level and quality, not tallied, and every grade carries a reason. The synthesis ends with one claim the proposal is allowed to make and one it is not.
2

Graded, Not Counted: Appraising the Evidence on Checking Criteria Before C. difficile Testing With the Johns Hopkins Tool

The Appraisal Method

Each source found in the Topic 2 search was appraised with the Johns Hopkins Nursing Evidence-Based Practice model, which assigns a level from I to V by design and a quality grade of A, B or C (Dang et al., 2022). Level I covers randomized trials and systematic reviews of them; Level II, quasi-experimental studies; Level III, non-experimental studies; Level IV, clinical practice guidelines and consensus statements; and Level V, quality improvement projects, literature reviews and expert opinion. Quality is graded separately: A for consistent, generalizable results with adequate samples and control, B for reasonably consistent results with some limitations, and C for little evidence, inconsistent results or serious limitations. The two judgments are independent, so a guideline can be Level IV and quality A, and a quasi-experimental study Level II and quality C.

The Appraisal Table

Table 1 appraises the six sources carried forward: four studies, one guideline and one consensus compendium, plus a commentary logged for context.

Table 1

Evidence Appraisal Using the Johns Hopkins Levels and Quality Grades

SourceDesign and settingSampleOutcomeLevelQualityReason for grade
McDonald et al. (2018)Clinical practice guideline, IDSA and SHEASystematic evidence review by expert panelTesting criteriaIVAGraded methods, national societies, explicit recommendations
Kociolek et al. (2023)Consensus compendium, SHEA, IDSA and APICExpert panel review of literaturePrevention practices, including diagnostic stewardshipIVATransparent development; recommends diagnostic stewardship as essential
Christensen et al. (2019)Quasi-experimental, one academic center, with a non-intervention unit as controlAdult inpatients over 52 monthsHospital-onset infection rateIIBControl unit and time-series analysis strengthen it; single site; intervention combined attestation, preauthorization and feedback, so effects cannot be separated
Truong et al. (2017)Before-and-after, one academic hospitalAll inpatient tests in both periodsTests meeting criteria; infection ratesIIBObjective electronic data and large volume; no concurrent control; relies on an electronic system our floor does not have
Madden et al. (2020)Retrospective case-control, one academic center637 patients, prevented vs negative testsMortality or ICU transferIIIBAddresses safety of holding tests; retrospective, one site
Joslin et al. (2022)Staged quality improvement project, one hospital system311 chartsAdherence to testing algorithmVCThree changes introduced in sequence; outcomes counted by the project team; no control
Rock & Maragakis (2019)CommentaryNoneNoneVBExpert opinion from infection prevention leaders; context, not evidence of effect

Weighing the Studies

The four studies agree in direction: checking criteria before testing reduced inappropriate tests or reported hospital-onset infections at each site. But agreement among weak designs is not strong evidence, and counting four studies as four votes would overstate what they show. The strongest study, Christensen et al. (2019), earns more weight than the others combined, because it is the only one with a comparison group that did not receive the intervention, and the only one that analyzed trends over time rather than comparing two averages. Even so, its intervention combined three components, provider attestation, stewardship preauthorization and feedback, so it cannot say which part mattered.

Truong et al. (2017) is useful because its data were objective, drawn from the electronic record rather than counted by hand, and the volume was large. But it had no concurrent control, so a hospital-wide change during the same period could explain some of the effect. Joslin et al. (2022) is graded C because three interventions were introduced in stages, the outcome was measured by the team running the project, and there was no comparison group; it shows the approach can be implemented, not that it works.

What this page is doingEvery grade carries a reason in the table, and the guideline and compendium are rated as Level IV sources rather than studies. The highlighted sentence explains why one controlled study outweighs several uncontrolled ones. The weaker projects are credited for what they can show and no more.
3

Safety and the Gap

Holding a test raises a safety question: could a patient with real infection be missed? Madden et al. (2020) addressed this directly, finding that patients whose tests were prevented by a decision support tool did not have worse outcomes than patients whose tests were negative. That is reassuring but retrospective and from one center.

The largest gap is the one most relevant to this project. None of the studies tested a check completed by nurses alone; each used prescriber attestation, stewardship review or electronic tools. No systematic review of diagnostic stewardship for C. difficile testing was found in the search. The guideline and compendium, both graded A, recommend testing only patients who meet criteria and recommend diagnostic stewardship, but do not specify who should do the checking (Kociolek et al., 2023; McDonald et al., 2018).

Applicability to This Floor

Quality and applicability are separate questions. A study can be well designed and still describe a setting unlike the composite medical floor. Three of the four studies came from academic medical centers with electronic tools or stewardship pharmacists reviewing every order, resources the floor does not have on nights. The floor's advantage is that its nurses already chart stool frequency and see the medication record, so the information a check needs is at hand. The fit is therefore partial: the evidence supports the principle of checking before testing, and the floor supplies the people who can do it, but no study has shown that this particular combination works. That is the reason the project measures the process, tests meeting criteria, rather than claiming an effect on infection.

What the Proposal May and May Not Say

The proposal may say: "Consistent evidence from national guidelines and several single-site studies supports checking recent laxative use and stool frequency before sending a C. difficile test, and one retrospective study suggests that holding tests that do not meet criteria is safe."

The proposal may not say: "Evidence shows that a nurse-completed checklist will reduce hospital-onset C. difficile infection." No study tested a nurse-only check, and no study on the list was designed to show an effect on true infection. The project will therefore measure what the evidence supports, the percentage of tests meeting criteria, and will report whether a nurse-completed check achieves it on this floor. That is a claim a nurse manager can act on, and one the evidence can bear.

References

Christensen, A. B., Barr, V. O., Martin, D. W., Anderson, M. M., Gibson, A. K., Hoff, B. M., Sutton, S. H., Widmaier, V., Salim, A. A., Silkaitis, C., Qi, C., Zembower, T. R., Postelnick, M. J., & Rhodes, N. J. (2019). Diagnostic stewardship of C. difficile testing: A quasi-experimental antimicrobial stewardship study. Infection Control & Hospital Epidemiology, 40(3), 269-275. https://doi.org/10.1017/ice.2018.336

Dang, D., Dearholt, S. L., Bissett, K., Ascenzi, J., & Whalen, M. (2022). Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and guidelines (4th ed.). Sigma Theta Tau International.

Joslin, J., Ablah, E., Okut, H., Bricker, L., & Assi, M. (2022). Improving stewardship of Clostridioides difficile testing with EMR and provider phone calls. Kansas Journal of Medicine, 15(1), 135-138. https://doi.org/10.17161/kjm.vol15.15884

Kociolek, L. K., Gerding, D. N., Carrico, R., Carling, P., Donskey, C. J., Dumyati, G., Kuhar, D. T., Loo, V. G., Maragakis, L. L., Pogorzelska-Maziarz, M., Sandora, T. J., Weber, D. J., Yokoe, D., & Dubberke, E. R. (2023). Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update. Infection Control & Hospital Epidemiology, 44(4), 527-549. https://doi.org/10.1017/ice.2023.18

Madden, G. R., Enfield, K. B., & Sifri, C. D. (2020). Patient outcomes with prevented vs negative Clostridioides difficile tests using a computerized clinical decision support tool. Open Forum Infectious Diseases, 7(4), Article ofaa094. https://doi.org/10.1093/ofid/ofaa094

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., Loo, V., Shaklee Sammons, J., Sandora, T. J., & Wilcox, M. H. (2018). Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases, 66(7), e1-e48. https://doi.org/10.1093/cid/cix1085

Rock, C., & Maragakis, L. L. (2019). Diagnostic stewardship for Clostridiodes difficile testing: From laxatives to diarrhea and beyond. Clinical Infectious Diseases, 71(6), 1479-1480. https://doi.org/10.1093/cid/ciz982

Truong, C. Y., Gombar, S., Wilson, R., Sundararajan, G., Tekic, N., Holubar, M., Shepard, J., Madison, A., Tompkins, L., Shah, N., Deresinski, S., Schroeder, L. F., & Banaei, N. (2017). Real-time electronic tracking of diarrheal episodes and laxative therapy enables verification of Clostridium difficile clinical testing criteria and reduction of Clostridium difficile infection rates. Journal of Clinical Microbiology, 55(5), 1276-1284. https://doi.org/10.1128/JCM.02319-16

What the NSG 448 Topic 3 instructions ask for

Topic 3 in NSG-448 asks students to appraise the evidence for their capstone. Strong papers name the appraisal tool, assign each source a level by design and a quality rating with reasons and present the results in a table. Students should weigh the body of evidence, noting where agreement among weaker designs falls short of proof, examine any safety question the change raises and judge applicability to their own setting separately from quality. The paper should end by stating exactly what the proposal may and may not claim, and evidence made up of quality improvement projects can still support a change if its limits are stated.

Inside the NSG 448 Topic 3 example

The appraisal table is the working center: one row per source, with design, setting, sample, the outcome measured, the Johns Hopkins level from I to V and a quality grade of A, B or C, followed by a column headed reason for grade. That last column carries the argument. Several single-site before-and-after projects agree that nurse-driven protocols shortened catheter duration, and the paper grades them low on quality, noting no comparison group, short follow-up and outcomes counted by the people running the project. A systematic review of interventions that reduce unnecessary catheter use is graded higher and given more weight than the small projects combined. The CDC guideline is rated as a clinical practice guideline, not a study. The synthesis ends with a sentence the proposal is allowed to say and one it is not.

Reading the NSG 448 Topic 3 rubric

Faculty reward evidence graded and its limits turned into claims. An Excellent paper tables six sources with Johns Hopkins levels and quality ratings, after Dang and colleagues. Credit goes to noting that four single-site studies agree in direction without that making the effect certain. The rubric values examining whether held tests miss true infection, with Madden and colleagues, and the Kociolek and colleagues compendium. Strong papers judge applicability to the floor separately. Top marks go to sentences the proposal may and may not use.

NSG 448 Topic 3 help before you submit

Counting in place of appraising still costs more marks here than anything else. A paper noting that seven of nine studies support the protocol has reported a vote, not a judgment, and faculty read it that way. Grades given without reasons are hard to credit, however accurate. Evidence levels assigned carelessly are a quieter problem, typically a quality improvement project rated as though it were a trial. Treating the CDC guideline as one more study undervalues it in one sense and misclassifies it in another. The most consequential slip is the ending: an appraisal that closes with a call for further research has left the proposal nothing to stand on. Strong versions end on a bounded claim a nurse manager could act on.

Get an NSG-448 Topic 3 example written to your instructions

Send the NSG-448 Topic 3 instructions and the rubric from your classroom, with the sources your search kept and the appraisal tool your section names. We write a custom example to those criteria, with every source graded and the grade explained, weak agreement discounted and a claim the evidence supports, in 24 to 48 hours. The first is free.

More NSG 448 papers and BSN samples

NSG 448 Topic 3 questions, answered

Which appraisal tool is standard for this capstone?

The Johns Hopkins Nursing Evidence-Based Practice model is common in nursing programs, with separate tools for research and non-research evidence and a level and quality rating for each source. Some sections use the Melnyk and Fineout-Overholt hierarchy or CASP checklists instead. Use the one your rubric names and apply it to every source, since mixing tools makes the grades impossible to compare.

What if the best evidence is only quality improvement projects?

Say so, grade them honestly and let the claim shrink to fit. Many practice problems have few trials behind them, and a proposal can still rest on consistent lower-level evidence plus a national guideline, provided it does not describe that base as stronger than it is. What a unit leader needs is an accurate statement of confidence, not the appearance of certainty.

Can the appraisal end by saying more research is needed?

It can note gaps, but it should not end there. The capstone is building toward a change someone could approve, so the appraisal's last move is to state what the current evidence justifies doing now and with what confidence. Unanswered questions belong in a sentence about limitations or in the evaluation plan, where the project itself can help answer them.

Where can I find a free NSG 448 Topic 3 sample paper?

The appraisal for NSG 448 Topic 3 covers the appraisal method, the appraisal table, weighing the studies, safety and the gap, applicability to the floor and what the proposal may and may not say. Post your NSG 448 Topic 3 prompt and get a free paper.

Can the appraisal end by saying more research is needed in NSG 448 Topic 3?

It can note gaps, but it should also say what the current evidence supports. Here it supports a pilot with monitoring, which is a decision, not a deferral.